The impact of immune checkpoint inhibitors on prognosis in unresectable hepatocellular carcinoma treated with TACE and lenvatinib: a meta-analysis

BackgroundCombination of multiple therapies is a common approach to treating patients with unresectable hepatocellular carcinoma (uHCC). The impact of immune checkpoint inhibitors (ICIs) on prognosis in uHCC patients treated with transarterial chemoembolization (TACE) and lenvatinib remains unclear....

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Wei Zhang, Zirong Liu, Hongjin Liu, Zhangkan Huang, Xiaozhun Huang, Lin Xu, Xu Che, Zhengyin Zhan
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2025-05-01
Reeks:	Frontiers in Immunology
Onderwerpen:	hepatocellular carcinoma transarterial chemoembolization lenvatinib immune checkpoint inhibitor PD-1 inhibitor
Online toegang:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1573505/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!